<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE314nnn/GSE314199/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314199</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptional profile of Influenza H3-specific memory B cells following LAIV vaccination [LAIV.bulkRNAseq]</name><description>Live attenuated influenza vaccination (LAIV) is the only FDA approved mucosal vaccine. Here, we determined the transcriptional profile of circulating memory B cell subsets that arise 14 days after LAIV vaccination. We used the expression of FcRL5 as a surrogate marker of Tbet+ memory B cells to compare the differences between these memory subsets. Influenza HA-B-cell tetramers were used to isolate vaccine-specific circulating cells for RNA-seq. These data highlight the differences and similarities between memory B cell subsets that arise following mucosla and intramuscular vaccination.</description><dates><publication>2026/08/24</publication></dates><accession>GSE314199</accession><cross_references><GSM>GSM9384854</GSM><GSM>GSM9384855</GSM><GSM>GSM9384856</GSM><GSM>GSM9384851</GSM><GSM>GSM9384852</GSM><GSM>GSM9384853</GSM><GPL>24676</GPL><GSE>314199</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>